Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Share of capital allocation among big biotechs in U.S. and Europe by type 2014-2019

M&A activity accounted for 39 percent of the total capital allocation among big biotechs in 2019, versus share repurchases which accounted for 13 percent of total capital allocation. The statistic illustrates the distribution of capital allocation among big biotechs in the U.S. and Europe, between 2014 and 2019, by type of activity.

Share of big biotech capital allocation in the U.S. and Europe from 2014 to 2019, by type

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2020

Region

Europe, United States

Survey time period

2014 to 2019

Special properties

U.S. and Europe biotech commercial leaders

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "European medical technology industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.